Causio Francesco Andrea, Hoxhaj Ilda, Beccia Flavia, Di Marcantonio Marzia, Strohäker Timo, Cadeddu Chiara, Ricciardi Walter, Boccia Stefania
Section of Hygiene, University Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
Faculty of Economics, Università Cattolica del Sacro Cuore, Rome, Italy.
Digit Health. 2022 Oct 26;8:20552076221129060. doi: 10.1177/20552076221129060. eCollection 2022 Jan-Dec.
Several countries are either planning or implementing national strategies for the development and integration of Personalized Medicine (PM) into their healthcare systems. Personalized Medicine is an undisputed priority of the European Commission (EC), which has funded the project "Integrating China into the International Consortium for Personalized Medicine" (IC2PerMed), in order to ensure a common basis for Sino-European collaborations. By mapping the current PM landscape in the European Union (EU) and in China, IC2PerMed aims to provide key solutions toward a synergistic and coordinated approach in the field of PM.
An extensive desk research was conducted, aimed at identifying documents on PM-related policies, programs, and action plans in the EU and in China, published up to November 2020. The search was conducted by exploring scientific and gray literature, and official institutional repositories. A descriptive summary condensed the information retrieved for both.
Since 2013, the year of publication of the first PM policy by the EC "Use of omics technologies in PM development," several documents have been published. PM is a key element of the policy agenda also in China, which in 2016 integrated PM into the 13th National Five-Year Plan, followed by the publication of several policies on technology infrastructure and big data. Both in the EU and China, especially in recent years, these policies addressed in detail the issues of big data, data interoperability and exchange, while defining the standards of information and communication infrastructures.
In order to allow optimal collaboration, it is essential to understand similarities and differences between the respective policy strategies, with particular attention to data management and adopted infrastructures. The results of this project may enable the development of joint Sino-European research and innovation initiatives, promoting developments in the field of PM.
几个国家正在规划或实施将精准医学(PM)发展并整合到其医疗体系中的国家战略。精准医学是欧盟委员会(EC)无可争议的优先事项,该委员会资助了“将中国纳入精准医学国际联盟”(IC2PerMed)项目,以确保中欧合作的共同基础。通过描绘欧盟(EU)和中国当前的精准医学格局,IC2PerMed旨在为精准医学领域的协同和协调方法提供关键解决方案。
进行了广泛的案头研究,旨在识别截至2020年11月在欧盟和中国发布的与精准医学相关的政策、计划和行动计划的文件。通过探索科学文献、灰色文献和官方机构知识库进行搜索。一份描述性摘要汇总了为两者检索到的信息。
自2013年欧盟委员会发布首份精准医学政策“组学技术在精准医学发展中的应用”以来,已发布了若干文件。精准医学也是中国政策议程的关键要素,中国在2016年将精准医学纳入第十三个国家五年计划,随后发布了多项关于技术基础设施和大数据的政策。在欧盟和中国,尤其是近年来,这些政策详细阐述了大数据、数据互操作性和交换问题,同时定义了信息和通信基础设施的标准。
为了实现最佳合作,了解各自政策战略之间的异同至关重要,尤其要关注数据管理和采用的基础设施。该项目的结果可能有助于开展中欧联合研究和创新举措,推动精准医学领域的发展。